New exec director

New exec director


Milton Park-based Oxford BioTherapeutics has welcomed Dr John McHutchison, executive vice president in clinical research for Gilead Sciences, to its board. Dr McHutchison has 20 years' clinical and drug development experience, including Gilead's programmes in liver diseases, haematology, oncology, inflammatory and respiratory diseases.



from Biotech News